Nootropics Index - Save on smarter supplements
Isolated phytochemicals & plant compounds

Methylliberine

Methylliberine

Methylliberine is a purine alkaloid sold as Dynamine and often positioned near caffeine and theacrine. Human evidence is small, acute and often formula-specific: studies report affect or vigilance signals in some settings, while a 2023 study found affect changes without cognitive-function improvement. Buyer comparisons should distinguish standalone products from blends, use the directly studied dose context, and avoid inferring long-term, sleep, or standalone cardiovascular effects from short-term combination research.

Focus SupportAttention SupportMental EnergyWakefulnessFatigue ResistancePhysical PerformanceAdenosine Related
Updated August 2026/5 min read/5 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What it is

1

Methylliberine is a purine alkaloid marketed under the branded ingredient name Dynamine. It is commonly sold as a standalone capsule or in acute energy formulas with caffeine and theacrine.

Evidence snapshot2
Human evidence is limited and mostly acute. The cleanest interpretation is possible energy, affect or vigilance support, with mixed cognitive findings and strong dependence on whether caffeine and theacrine are also present.

Brand name

1

Many studies and product labels use the branded Dynamine name for methylliberine.

Common formula companions

4

Methylliberine is often paired with caffeine and TeaCrine/theacrine, which makes standalone attribution difficult.

Mixed cognitive signal

2

A 2023 study reported improvements in affect measures but not cognitive function. That should temper strong focus, memory or productivity claims, especially for standalone products.

02

Names, aliases and forms

Common NameMethylliberine
Brand NameDynamine
Chemical Name2-methoxy-1,7,9-trimethylpurine-6,8-dione
Active ConstituentPurine alkaloid
03

Mechanisms of action

Caffeine-adjacent purine alkaloid

1

Methylliberine is usually discussed near caffeine-like purine alkaloids. The practical buyer implication is acute stimulation and label-stacking risk, not established brain-health benefit.

04

Potential effects and evidence map

Methylliberine has a small human literature, including short-term safety work, an affect/cognition study, tactical-vigilance research, and combination studies with caffeine and theacrine. The evidence is more suggestive than settled: some studies report affect, reaction-time or vigilance signals, while a 2023 study found affect changes without cognitive-function improvement. The practical profile is best regarded as acute stimulant-like support, not a durable nootropic or brain-protection compound.

Effect domainMagnitudeGrade
Mental energy / wakefulness3
AcuteConfidence: Medium

Small acute studies support possible energy, affect or vigilance effects, especially in stimulant-combination contexts.

Note Separate standalone methylliberine from caffeine/theacrine blends.

2/5
C
Focus / attention2
AcuteConfidence: Low

Focus and cognition evidence is mixed; one study found affect improvements without cognitive-function improvement.

Note Avoid strong nootropic claims.

1/5
C
Physical energy / endurance3
AcuteConfidence: Low

Physical-performance relevance is mostly through stimulant formulas and tactical-vigilance contexts, not robust endurance evidence.

Note Do not overstate exercise performance benefits.

1/5
D
05

Typical dosages and timing

Typical
100-150 mg/day
Not a recommendation
Lower bound
100 mg
Profile value
Upper bound
150 mg
Profile value
not a recommendation1100-150 mg/day in short-term studies

Short-term human studies used 100-150 mg/day, with or without theacrine. Those study conditions do not create a consumer dose target.

formula math3include caffeine

For blends, compare the stated caffeine and theacrine amounts as well as methylliberine. A combination study cannot identify which component explains a given effect.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
Timing evidence gap2

Available human studies are acute or short-term and do not establish a definitive onset, duration, late-day use, or sleep-effect profile.

07

Safety, side effects and risk profile

Stimulant stack caution3
Methylliberine is often sold with caffeine or theacrine. Combination research cannot attribute a result to methylliberine alone, so compare the complete formula before comparing products.
Overstimulation / insomnia2
Confidence: Medium

Available methylliberine studies do not establish sleep effects or a late-day safety profile, particularly for caffeine/theacrine blends.

Note Do not convert acute or short-term evidence into a sleep-risk estimate.

1/5
E
Cardiovascular caution3
Confidence: Medium

In a caffeine, methylliberine and theacrine combination study, systolic blood pressure increased versus placebo; the study did not report a heart-rate increase.

Note This combination finding does not establish a standalone methylliberine effect.

1/5
C
Headache / dizziness1
Confidence: Medium

The reviewed short-term human studies do not establish a reliable methylliberine-only headache or dizziness adverse-effect profile.

Note Combination products make attribution uncertain.

1/5
E
Interaction risk3
Confidence: Medium

Combination studies cannot separate methylliberine from caffeine and theacrine, so the contribution of each ingredient to tolerability or hemodynamic effects remains uncertain.

Note Compare the entire formula rather than assuming a standalone effect.

1/5
C
Pregnancy / lactation caution1
Confidence: Low

No pregnancy or lactation data were identified for concentrated methylliberine products; do not infer safety from short-term studies in healthy adults.

Note This is an evidence-gap caution, not a trial-derived adverse-effect claim.

1/5
E
Evidence uncertainty2
Confidence: High

The literature is small, often branded, acute and formula-dependent; long-term daily safety and standalone nootropic benefit remain uncertain.

Note Evidence should be graded lower than caffeine's evidence base.

1/5
C
not a standalone profile3evidence gap

Available studies do not establish a methylliberine-only side-effect profile, elevated-heart-rate finding, or sleep-disruption effect. Check all coingredients in stimulant blends.

systolic blood pressure3combination result

In a caffeine, methylliberine and theacrine combination study, systolic blood pressure increased versus placebo, while no heart-rate increase was reported. This does not establish a standalone methylliberine effect.

08

Practical buying and quality notes

  • A standalone Dynamine capsule is not comparable to an enhanced caffeine product. Compare the whole Supplement Facts panel and total stimulant dose before comparing prices.4
  • Avoid proprietary blends that hide caffeine, methylliberine or theacrine amounts. Stimulant formulas should make it easy to cap daily exposure.1
  • Listings that imply long-lasting cognitive enhancement, brain-protection claims or daily energy without tolerance concerns go beyond the current evidence base.2
09

FAQ

Is Methylliberine just caffeine?

3

No. It is a distinct purine alkaloid, but buyers should regard it as caffeine-adjacent in practical risk terms because many formulas combine it with caffeine and theacrine.

Does Methylliberine improve cognition?

2

Evidence is mixed and limited. A 2023 standalone methylliberine study reported affect changes without cognitive-function improvement.

Who should be cautious first?

1

Pregnancy and lactation data were not identified, and available human studies do not establish sleep effects. Anyone considering a high-stimulant blend should assess the complete label rather than assume short-term study data apply.

10

References

  1. VanDusseldorp TA, Stratton MT, Bailly AR, Holmes AJ, et al. Safety of Short-Term Supplementation with Methylliberine (Dynamine) Alone and in Combination with TeaCrine in Young Adults. Nutrients. 2020;12(3):654.
  2. La Monica MB, Raub B, Malone K, Hartshorn S, et al. Methylliberine Ingestion Improves Various Indices of Affect but Not Cognitive Function in Healthy Men and Women. Nutrients. 2023;15(21):4509.
  3. Cintineo HP, Bello ML, Chandler AJ, Cardaci TD, et al. Effects of caffeine, methylliberine, and theacrine on vigilance, marksmanship, and hemodynamic responses in tactical personnel: a double-blind, randomized, placebo-controlled trial. J Int Soc Sports Nutr. 2022;19(1):543-564.
  4. Tartar JL, Banks JB, Marang M, Pizzo F, et al. A Combination of Caffeine, TeaCrine and Dynamine Increases Cognitive Performance and Reaction Time Without Interfering With Mood in Adult Male Egamers. Cureus. 2021;13(12):e20534.
  5. PubChem. Methylliberine. Compound CID 15872156.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.